Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
9.52
-0.06 (-0.63%)
At close: Sep 17, 2025, 4:00 PM EDT
9.24
-0.28 (-2.94%)
After-hours: Sep 17, 2025, 5:54 PM EDT
SPRB's stock price has decreased by -72.17% in the past year and price targets may not have had time to catch up.
Spruce Biosciences Analyst Ratings
Total Analysts
5
Consensus Rating
Hold
Price Target
$131.25
Upside
+1,278.68%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $113 → $38 | Hold | Maintains | $113 → $38 | +293.91% | Apr 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 16, 2024 |
| Guggenheim | Guggenheim | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 12, 2024 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades $225 | Buy → Hold | Downgrades | $225 | +2,263.45% | Dec 11, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $150 → $113 | Hold | Reiterates | $150 → $113 | +1,081.72% | Dec 11, 2024 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 11, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $150 | Hold | Reiterates | $150 | +1,475.63% | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 19, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $150 | Hold | Reiterates | $150 | +1,475.63% | Aug 13, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $300 → $225 | Buy | Maintains | $300 → $225 | +2,263.45% | Jun 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jun 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 14, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $675 → $150 | Buy → Hold | Downgrades | $675 → $150 | +1,475.63% | Mar 14, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $600 → $225 | Buy | Maintains | $600 → $225 | +2,263.45% | Mar 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 14, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $675 → $150 | Buy → Hold | Downgrades | $675 → $150 | +1,475.63% | Mar 14, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.